FDA approves Lexicon Pharma`s carcinoid syndrome diarrhea drug

Published 9y ago

The U.S. Food and Drug Administration said on Tuesday it had approved Lexicon Pharmaceuticals Inc’s oral drug to treat carcinoid syndrome diarrhea, a condition that develops in patients with gastrointestinal tumors. More »